alexa Abstract | Docking studies of Benzimidazole Schiff bases with Mycobacterium tuberculosis 3HNT Protein

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The re-emergence of tuberculosis (TB) as a global health problem over the past few decades, accompanied by the rise of drug-resistant strains of Mycobacterium tuberculosis, emphasizes the need for discovery of new therapeutic drugs against this disease. The emerging serious problem both in terms of TB control and clinical management prompted us to synthesize a novel series of heterocyclic compounds and determine their activity against 3HNT protien of Mycobacterium. All compounds inhibited the growth of the 3HNT strain of mycobacterium at concentrations as low as 1 mg/mL

To read the full article Peer-reviewed Article PDF image

Author(s): D Prabhakara Chary V Krishnaa R Premalathab and B Sandhya Ranib


Lipoarabinomannan(LAM), M. tuberculosis, docking, Imidazolopyridine drugs, Schiff bases,Docking

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version